AbbVie (ABBV) Short term Debt (2012 - 2025)

AbbVie (ABBV) has 14 years of Short term Debt data on file, last reported at $2.5 billion in Q4 2025.

• Short term Debt for Q4 2025 came in at $2.5 billion, down 63.27% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 billion (down 63.27% YoY), and the FY2025 annual result was $2.5 billion, down 63.27% from the prior year.
• Short term Debt rose to $2.5 billion in Q4 2025 per ABBV's latest filing, from $2.0 billion in the prior quarter.
• Over five years, Short term Debt peaked at $12.6 billion in Q2 2024 and troughed at $3.0 million in Q1 2024.
• A 5-year average of $5.9 billion and a median of $5.1 billion in 2023 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2021 and 2022: Short term Debt surged 188866.67% in 2021, then tumbled 99.89% in 2022.
• A 5-year view of Short term Debt shows it stood at $12.5 billion in 2021, then sank by 66.87% to $4.1 billion in 2022, then jumped by 73.91% to $7.2 billion in 2023, then decreased by 5.38% to $6.8 billion in 2024, then plunged by 63.27% to $2.5 billion in 2025.
• Business Quant data shows ABBV's Short term Debt at $2.5 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.0 billion in Q2 2025.